Published in J Antimicrob Chemother on May 04, 2005
Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev (2007) 15.82
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev (2012) 5.65
Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor. Antimicrob Agents Chemother (2010) 1.87
CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis (2009) 1.32
Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence. J Am Chem Soc (2009) 1.16
Systematic analysis of metallo-β-lactamases using an automated database. Antimicrob Agents Chemother (2012) 1.08
Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria. Infect Drug Resist (2015) 1.00
NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis. Biochemistry (2012) 0.98
Role of zinc content on the catalytic efficiency of B1 metallo beta-lactamases. J Am Chem Soc (2007) 0.91
Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination of β-Lactam Resistance Genes among the Enterobacteriaceae. Biomed Res Int (2015) 0.84
Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis. Biochemistry (2014) 0.83
A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1. J Comput Aided Mol Des (2013) 0.81
Biapenem inactivation by B2 metallo β-lactamases: energy landscape of the post-hydrolysis reactions. PLoS One (2012) 0.81
Identification of group specific motifs in beta-lactamase family of proteins. J Biomed Sci (2009) 0.80
Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study. PLoS One (2014) 0.79
Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010). Iran J Microbiol (2012) 0.79
Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases. PLoS Comput Biol (2016) 0.78
One origin for metallo-β-lactamase activity, or two? An investigation assessing a diverse set of reconstructed ancestral sequences based on a sample of phylogenetic trees. J Mol Evol (2014) 0.77
GMP and IMP Are Competitive Inhibitors of CMY-10, an Extended-Spectrum Class C β-Lactamase. Antimicrob Agents Chemother (2017) 0.75
Enantioselective Synthesis and Profiling of Two Novel Diazabicyclooctanone β-Lactamase Inhibitors. ACS Med Chem Lett (2014) 0.75
The role of conserved surface hydrophobic residues in the carbapenemase activity of the class D β-lactamases. Acta Crystallogr D Struct Biol (2017) 0.75
Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase. Genetics (2002) 1.95
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother (2005) 1.88
Evolution of the serine beta-lactamases: past, present and future. Drug Resist Updat (2004) 1.77
Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii. Antimicrob Agents Chemother (2002) 1.75
Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol Rev (2010) 1.60
Phylogenetic analysis shows that the OXA beta-lactamase genes have been on plasmids for millions of years. J Mol Evol (2002) 1.43
Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC beta-lactamase. Genetics (2003) 1.29
Growth rates made easy. Mol Biol Evol (2013) 1.29
The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. PLoS One (2011) 1.28
Experimental prediction of the natural evolution of antibiotic resistance. Genetics (2003) 1.21
Inadequacies of minimum spanning trees in molecular epidemiology. J Clin Microbiol (2011) 1.15
Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol (2012) 1.13
Phylogenetic analysis as a tool in molecular epidemiology of infectious diseases. Ann Epidemiol (2005) 1.13
Comparative supragenomic analyses among the pathogens Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae using a modification of the finite supragenome model. BMC Genomics (2011) 1.11
The metallo-beta-lactamases fall into two distinct phylogenetic groups. J Mol Evol (2003) 1.03
Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. J Microbiol (2012) 1.02
The peaks and geometry of fitness landscapes. J Theor Biol (2012) 1.00
Structure-based phylogeny of the metallo-beta-lactamases. Antimicrob Agents Chemother (2005) 1.00
Structure-based phylogenies of the serine beta-lactamases. J Mol Evol (2003) 0.99
Determining the limits of the evolutionary potential of an antibiotic resistance gene. Mol Biol Evol (2003) 0.98
Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg Infect Dis (2006) 0.97
Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrob Agents Chemother (2005) 0.95
GeneHunter, a transposon tool for identification and isolation of cryptic antibiotic resistance genes. Antimicrob Agents Chemother (2003) 0.95
Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes. PLoS One (2013) 0.94
Fitness trade-offs in blaTEM evolution. Antimicrob Agents Chemother (2008) 0.93
Independent origins of subgroup Bl + B2 and subgroup B3 metallo-beta-lactamases. J Mol Evol (2004) 0.90
Evolution and recombination of the plasmidic qnr alleles. J Mol Evol (2008) 0.89
Using complete genome comparisons to identify sequences whose presence accurately predicts clinically important phenotypes. PLoS One (2013) 0.88
Recombination and selection can remove blaTEM alleles from bacterial populations. Antimicrob Agents Chemother (2008) 0.86
Remembrances of Walter M. Fitch. Mol Biol Evol (2011) 0.83
Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals. PLoS One (2011) 0.83
Clustering acinetobacter strains by optical mapping. Genome Biol Evol (2013) 0.81
Retraction: Measures of clade confidence do not correlate with accuracy of phylogenetic trees. PLoS Comput Biol (2007) 0.79
A Mycobacterium leprae VNTR database. Lepr Rev (2010) 0.78
Towards the molecular epidemiology of Mycobacterium leprae: strategies, successes, and shortcomings. Infect Genet Evol (2011) 0.78
α-Galacturonidase(s): a new class of Family 4 glycoside hydrolases with strict specificity and a unique CHEV active site motif. FEBS Lett (2013) 0.77
Correction: Rational Design of Antibiotic Treatment Plans: A Treatment Strategy for Managing Evolution and Reversing Resistance. PLoS One (2015) 0.75